Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe bleeding diathesis associated with moxalactam administration.

S Meisel

    Drug Intelligence & Clinical Pharmacy
    |September 1, 1984
    PubMed
    Summary

    Severe bleeding diathesis linked to moxalactam was confirmed. This case highlights the need for careful patient monitoring during moxalactam therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Identification of Bacillus anthracis via Raman spectroscopy and chemometric approaches.

    Analytical chemistry·2012
    Same author

    Raman spectroscopic detection of anthrax endospores in powder samples.

    Angewandte Chemie (International ed. in English)·2012
    Same author

    Social appearance anxiety and bulimia nervosa.

    Eating and weight disorders : EWD·2011
    Same author

    Raman spectroscopy-compatible inactivation method for pathogenic endospores.

    Applied and environmental microbiology·2010
    Same author

    The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions.

    Neurology·2004
    Same author

    [Cortical blindness following coronary angiography].

    Harefuah·2000

    Area of Science:

    • Pharmacology
    • Hematology

    Background:

    • Moxalactam is a beta-lactam antibiotic.
    • Bleeding diathesis is a condition involving abnormal bleeding.

    Observation:

    • A patient developed a severe bleeding diathesis during moxalactam administration.
    • Symptoms resolved upon discontinuation and recurred upon rechallenge with moxalactam.

    Findings:

    • Moxalactam administration was causally linked to the severe bleeding diathesis.
    • Potential mechanisms include interference with vitamin K metabolism or platelet function.

    Implications:

    • Clinicians should be vigilant for bleeding complications in patients receiving moxalactam.
    • Recommendations for monitoring and management are discussed to prevent adverse events.

    Related Experiment Videos